What is PharmPak?
Established in 1983, PharmPak Inc. occupies a critical niche in the pharmaceutical supply chain, specializing in the repackaging and distribution of medications ready for immediate patient dispensing. By focusing on unit-dose blister-pack technology and customized labeling, the company addresses the persistent challenge of medication adherence and therapeutic compliance. Their service model is specifically engineered to support high-stakes healthcare environments, including surgery centers, senior care facilities, and public health departments. By streamlining the transition from bulk supply to patient-ready units, PharmPak effectively reduces administrative burdens for practitioners while ensuring strict adherence to federal regulatory standards.
How much funding has PharmPak raised?
PharmPak has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in PharmPak
PPP
Public-Private Partnership
What's next for PharmPak?
The recent strategic investment positions PharmPak to accelerate its infrastructure development and expand its reach into broader clinical markets. As the healthcare sector increasingly prioritizes patient-centric outcomes and operational efficiency, the company is well-positioned to leverage its late-stage capital to enhance its automated packaging capabilities and digital compliance tracking. Future growth trajectories will likely focus on deepening integration with electronic health record systems and scaling its logistics network to meet the rising demand for specialized medication management in aging populations. This financial backing provides the necessary runway to maintain its competitive edge in the evolving landscape of pharmaceutical distribution and patient care optimization.
See full PharmPak company page
